Topvision Eye Specialist Berhad
Topvision Eye Specialist Berhad, an investment holding company, engages in the provision of ophthalmology and related medical consultancy services in Malaysia. The company offers various eye care services comprising cataract, diabetic retinopathy, vitreous and retinal diseases, glaucoma, corneal, anterior segment diseases, age-related macular degeneration, pterygium, dry eyes, lid disorder, child… Read more
Topvision Eye Specialist Berhad (0332) - Net Assets
Latest net assets as of : RM- MYR
Based on the latest financial reports, Topvision Eye Specialist Berhad (0332) has net assets worth RM- MYR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM-) and total liabilities (RM-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Topvision Eye Specialist Berhad - Net Assets Trend (None–None)
This chart illustrates how Topvision Eye Specialist Berhad's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Topvision Eye Specialist Berhad (None–None)
The table below shows the annual net assets of Topvision Eye Specialist Berhad from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Topvision Eye Specialist Berhad's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Topvision Eye Specialist Berhad Competitors by Market Cap
The table below lists competitors of Topvision Eye Specialist Berhad ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Berto Acquisition Corp. Warrant
NASDAQ:TACOW
|
$1.63 Million |
|
ORACLE
BE:ORC
|
$1.63 Million |
|
RYDER SYSTEM - Dusseldorf Stock Exchang
DU:RYD
|
$1.63 Million |
|
ASTRAZENECA
HM:ZEG
|
$1.63 Million |
|
Correlate Infrastructure Partners Inc
OTCQB:CIPI
|
$1.63 Million |
|
Modern Healthcare Technology Holdings Limited
F:M3L
|
$1.63 Million |
|
Carmat SA
F:CXT
|
$1.62 Million |
|
Novolog Pharm-Up 1966 Ltd
TA:NVLG
|
$1.62 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Topvision Eye Specialist Berhad's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Topvision Eye Specialist Berhad's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Topvision Eye Specialist Berhad utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Topvision Eye Specialist Berhad's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,210,289,753
- Average return on equity (ROE) among peers: 30.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Topvision Eye Specialist Berhad (0332) | RM- | N/A | N/A | $1.63 Million |
| TMC Life Sciences Bhd (0101) | $48.97 Million | 18.72% | 0.24x | $32.96 Million |
| Optimax Holdings Sdn Bhd (0222) | $20.79 Million | 21.38% | 1.70x | $17.14 Million |
| Cengild Medical Berhad (0243) | $9.79 Million | 40.37% | 3.81x | $11.79 Million |
| DC HEALTHCARE HOLDINGS BERHAD (0283) | $4.75 Million | 39.98% | 2.55x | $5.67 Million |
| ALPHA (0303) | $54.55 Million | 97.60% | 0.76x | $70.68 Million |
| Metro Healthcare Berhad (0329) | $34.34 Million | 27.49% | 0.46x | $4.10 Million |
| PMCK Berhad (0363) | $81.09 Million | 13.23% | 0.33x | $421.93 |
| IHH Healthcare Bhd (5225) | $25.90 Billion | 3.74% | 0.50x | $6.11 Billion |
| KPJ Healthcare Bhd (5878) | $2.74 Billion | 12.92% | 1.70x | $1.99 Billion |